Physician

Haejin In, M.D.

According to 2025 Medicare claims, Haejin In, M.D. (NPI: 1932374246) practices surgical oncology in the Lakewood-New Brunswick, NJ market, with the plurality of this provider's patient population coming from Somerset, NJ. This provider's primary affiliated billing organization is RUTGERS HEALTH-RWJ SCLERODERMA PROGRAM (NPI: 1487688495; TIN: 223371727) and primary practice location at 08901-1928. In is affiliated with the Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under the REACH model.

In's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 46 traditional Medicare patients, billed 94 HCPCS/CPT codes, and received $13,758 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 14 prescription claims totaling $455 in drug costs. 2016 DME data shows 103 claims. Open Payments data shows 10 records totaling $5,249. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $9,380 and ending at $13,758. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $4,251 to $455. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$20K$40K2015 Medicare payment: $9,380 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $39,916 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $17,776 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $11,216 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $15,833 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $33,524 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $16,650 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $11,657 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $16,318 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $13,758 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20152555$9,380
201649151$39,916
20174691$17,776
20183494$11,216
20193580$15,833
202050121$33,524
20214485$16,650
20222367$11,657
20232964$16,318
20244694$13,758

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$2.1K$4.3K2015 Drug cost: $4,251 (USD; Tot_Drug_Cst)2016 Drug cost: $1,855 (USD; Tot_Drug_Cst)2017 Drug cost: $238 (USD; Tot_Drug_Cst)2018 Drug cost: $165 (USD; Tot_Drug_Cst)2019 Drug cost: $831 (USD; Tot_Drug_Cst)2020 Drug cost: $3,666 (USD; Tot_Drug_Cst)2021 Drug cost: $3,295 (USD; Tot_Drug_Cst)2024 Drug cost: $455 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/R19$4,251
20161527$1,855
20171933$238
2018N/R12$165
2019N/R19$831
20201728$3,666
20211323$3,295
2022N/RN/RN/R
2023N/RN/RN/R
2024N/R14$455

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$16K$32K2016 Medicare payment: $32,185 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/R103$32,185
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more1823$81
99232Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes1119$67

Top 5 Part D drugs in 2024

By total drug costs.

Part D summary data is connected for 2024, but public drug-level costs are not available, so a Top 5 by total drug costs cannot be shown.

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.10$5,249INTUITIVE SURGICAL, INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Haejin In, M.D.?

Tedicare shows public-source Medicare data for Haejin In, M.D. (NPI 1932374246), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Haejin In, M.D. have ACO affiliation data?

Haejin In, M.D. is shown with ACO affiliation data for Vytalize Health 9 ACO LLC (REACH, ACO ID D0313).

What billing organization is linked to Haejin In, M.D.?

Haejin In, M.D. is linked to RUTGERS HEALTH-RWJ SCLERODERMA PROGRAM (billing NPI 1487688495) in the available physician profile data.

Does Haejin In, M.D. have Open Payments data?

Haejin In, M.D. has 10 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.